Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of the American College of Cardiology

• Publication date

  1999-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(99)00424-6PMID 10577569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease

  2004cited by this paper
• Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease.

  1998cited by this paper
• Implementation of a computerized cardiovascular information system in a private hospital setting

  1998cited by this paper
• Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells.

  1998cited by this paper
• Associations of Fibrinogen, Factor VII and PAI-1 with Baseline Findings among 10,500 Male Participants in a Prospective Study of Myocardial Infarction

  1998cited by this paper
• Implementation of a computerized cardiovascular information system in a private hospital setting.

  1998cited by this paper
• Haemostatic risk factors for cardiovascular diseases.

  1998cited by this paper
• Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women.

  1998cited by this paper
• The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.

  1998cited by this paper
• Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function.

  1998cited by this paper
• High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

  1998cited by this paper
• The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease.

  1998cited by this paper
• Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.

  1997cited by this paper
• A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction.

  1997cited by this paper
• PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

  1997cited by this paper
• Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells.

  1997cited by this paper
• Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.

  1997cited by this paper
• Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.

  1996cited by this paper
• Haemostatic factors and atherogenesis.

  1996cited by this paper
• Plasminogen activator inhibitor-1 promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes

  1995cited by this paper
• Plasminogen Activator Inhibitor-1 (PAI-1) Promoter Polymorphism and Coronary Artery Disease in Non-Insulin-Dependent Diabetes

  1995cited by this paper
• The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

  1995cited by this paper
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

  1995cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• Plasminogen Activator Inhibitor 1 and Atherothrombosis

  1993cited by this paper
• Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men

  1993cited by this paper
• The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

  1993cited by this paper
• Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.

  1993cited by this paper
• Induction of Endothelial Cell Expression of the Plasminogen Activator Inhibitor Type 1 Gene by Thrombosis In Vivo

  1992cited by this paper
• Increased plasminogen activator inhibitor activity in survivors of myocardial infarction is associated with metabolic risk factors of atherosclerosis.

  1992cited by this paper
• Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.

  1991cited by this paper
• Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.

  1991cited by this paper
• A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction.

  1990cited by this paper
• Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.

  1988cited by this paper
• PLASMINOGEN ACTIVATOR INHIBITOR

  1987cited by this paper
• Genetic distances between the Utah Mormons and related populations.

  1984cited by this paper
• Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial.

  1984cited by this paper

• Genetic factors, risk prediction and AI application of thrombotic diseases

  2024cites this paper
• Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina

  2021cites this paper
• Genetic variations of Renin-angiontensin and Fibrinolytic systems and susceptibility to coronary artery disease: a population genetics perspective.

  2020cites this paper
• A general overview of systems theory, integrative physiology, and the theory of Endobiogeny

  2019cites this paper
• Impact of PAI-1 4G/5G and C > G polymorphisms in acute ST elevation myocardial infarction and stable angina patients: A single center Egyptian study

  2018cites this paper
• Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study

  2017cites this paper
• The role of genetic markers of thrombophilia in the development of thrombosis after coronary artery bypass graft surgery

  2016cites this paper
• The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease

  2016cites this paper
• Genetic Susceptibility to Cardiovascular Diseases: From Mendelian Disorders to Common Variants

  2016cites this paper
• PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.

  2015cites this paper
• Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy

  2015cites this paper
• PAI-1 4 G / 5 G polymorphism and coronary artery disease risk : a meta-analysis

  2015cites this paper
• Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease

  2015cites this paper
• Fibrinogen as a Biomarker in Vascular Disease and its Prognostic Impact During Venous and Arterial Thrombolysis

  2015cites this paper
• Fibrinogen and catheter-directed thrombolysis.

  2014cites this paper
• Relation of PAI-1 and TPA Genes Polymorphisms to Acute Myocardial Infarction and its Outcomes in Egyptian Patients

  2014cites this paper
• The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis

  2014cites this paper
• Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.

  2014cites this paper
• Molecular Genetics of Coronary Artery Disease and Myocardial Infarction

  2014cites this paper
• Endobiogeny: A Global Approach to Systems Biology (Part 1 of 2)

  2013cites this paper
• Thrombophilic Gene Mutations / Polymorphisms in Young Patients with Myocardial Infarction

  2013cites this paper
• Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

  2012cites this paper
• PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease.

  2011cites this paper
• PAI-1 4 G / 5 G Polymorphism and Plasma Levels Association in Patients with Coronary Artery Disease

  2011cites this paper
• Erratum

  2011cites this paper
• 4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene Is Associated with Multiple Organ Dysfunction in Critically Ill Patients

  2011cites this paper
• Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction

  2011cites this paper
• Allele-specific transcription of the PAI-1 gene in human astrocytes

  2010cites this paper
• On the Regulation of the Serine Protease t-PA and its Inhibitor PAI-1 in the Brain

  2010cites this paper
• 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries

  2010cites this paper
• Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction

  2010cites this paper
• The I allele of the angiotensin converting enzyme I/D polymorphism confers protection against coronary artery disease

  2010cites this paper
• Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease

  2008influential citation
• Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes.

  2008cites this paper
• Genetic determinants in ischemic heart disease.

  2008cites this paper
• CHAPTER 9 – Ischemia and Myocardial Infarction: A Post-Genomic Analysis

  2007cites this paper
• Insulin resistance after precocious pubarche: relation to PAI‐1–675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gain

  2007cites this paper
• Kandidatengene des Diabetes mellitus Typ 2

  2006cites this paper
• [Candidate genes and polymorphism analysis in type 2 diabetes mellitus].

  2006cites this paper
• Thrombophilic Polymorphisms and Intrauterine Growth Restriction

  2005cites this paper
• Genetic contributors toward increased risk for ischemic heart disease.

  2005cites this paper
• Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction

  2005cites this paper
• Parent-of-origin transmission of thrombophilic alleles to intrauterine growth-restricted newborns and transmission-ratio distortion in unaffected newborns.

  2005cites this paper
• Genetics and Gene Manipulation Therapy of Premature Coronary Artery Disease

  2004cites this paper
• Thrombophilia in coronary artery disease: a double jeopardy.

  2004cites this paper
• Genetic Basis of Acute Coronary Syndromes

  2004cites this paper
• Fibrinolysis, inflammation and cardiovascular disease; Epidemiological studies on Plasminogen activator inhibitor-type 1 and C-reactive protein

  2003cites this paper
• Lack of association of the plasminogen activator inhibitor‐1 4G/5G promoter polymorphism with cardiovascular disease in the elderly

  2003cites this paper
• 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.

  2003cites this paper
• The genetics of atherothrombotic disorders: a clinician's view

  2003cites this paper
• 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.

  2003cites this paper
• Genetic testing for coronary heart disease: the approaching frontier

  2002cites this paper
• The Association of PAI-1 Promoter 4G/5G Insertion/Deletion Polymorphism with Myocardial Infarction and Stroke in Young Women

  2002cites this paper
• Thrombophilia: hereditary and acquired in cardiovascular disease.

  2002cites this paper
• Coagulation and Fibrinolysis in Diabetes

  2002cites this paper
• Original Communication Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors

  2001cites this paper
• Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis.

  2001cites this paper
• The plasminogen activator inhibitor 1 4G/5G polymorphism is not associated with longevity: a study in octogenarians

  2001cites this paper
• Genetics of Arterial Prothrombotic Risk States

  2001cites this paper
• Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors

  2001cites this paper
• Genetic Variation in Coagulation and Fibrinolytic Proteins and Their Relation With Acute Myocardial Infarction: A Systematic Review

  2001cites this paper
• [Genetic risk factors for myocardial infarct].

  2000cites this paper
• Genetische Risikofaktoren für den Myokardinfarkt

  2000cites this paper
• Thrombophilia, polymorphisms, and vascular disease

  2000cites this paper
• Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism, Coronary Thrombosis, and Myocardial Infarction in Middle-aged Finnish Men who Died Suddenly

  2000influential citation